Skip to main content
Clinical Trials/NCT03656016
NCT03656016
Recruiting
Not Applicable

Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.

Assiut University1 site in 1 country87 target enrollmentMarch 25, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebrospinal Fluid
Sponsor
Assiut University
Enrollment
87
Locations
1
Primary Endpoint
To calculate different cerebrospinal fluid flow parameters at different levels of flow quantification.
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Cerebrospinal fluid is a clear, colorless fluid that circulates in the cranial and spinal subarachnoid spaces, located between the pia and arachnoid matters. It is mainly produced by the choroid plexus, while lesser amount produced by the ependymal cells lining the ventricles. Its function includes cushioning and lubrication of the central nervous system, circulation of nutrients and waste collection providing basic mechanical and immunological protection to the brain.

Detailed Description

There are several disorders such as communicating and non- communicating hydrocephalus, normal pressure hydrocephalus, cystic cerebrospinal fluid collections, Chiari malformation, syringomyelic cyst and arachnoid cyst that can change the cerebrospinal fluid dynamics. Rapid advances in imaging techniques have remarkably improved the diagnosis and treatment of these disorders. Phase contrast magnetic resonance imaging is a rapid, simple and non-invasive technique which is sensitive to even small cerebrospinal fluid flows, and can be used to evaluate cerebrospinal fluid flow both qualitatively and quantitatively. Cine phase contrast magnetic resonance images show cerebrospinal fluid flow in a dynamic, more easily appreciable, and in a more pleasing manner, allowing the delineation of obstruction, if present, along the portions of cerebrospinal fluid pathway where obstruction is common. Phase contrast magnetic resonance imaging can be used to discriminate between communicating hydrocephalus and non-communicating hydrocephalus, to localize the level of obstruction in obstructive hydrocephalus, to determine whether arachnoid cysts communicate with the subarachnoid space, to differentiate between arachnoid cysts and subarachnoid space, to discriminate between syringomyelia and cystic myelomalacia, and to evaluate flow patterns of posterior fossa cystic malformations. This imaging method can also provide significant information in pre-operative evaluation of Chiari 1 malformation and post-operative follow-up of patients with neuroendoscopic third ventriculostomy and ventriculoperitoneal shunt. The application of cine phase contrast magnetic resonance imaging technique in patients with normal pressure hydrocephalus holds great promise for improvement of the diagnosis, especially in those cases where the differentiation from atrophy on clinical and conventional radiological basis is difficult.

Registry
clinicaltrials.gov
Start Date
March 25, 2019
End Date
July 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shimaa Hassanien Hassanien Bakr

principal Investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Patients with different age groups and both sex with clinical and routine conventional magnetic resonance imaging findings suggestive of cerebrospinal fluid flow disorders.

Exclusion Criteria

  • Patients with contraindications for MRI, e.g. an implanted magnetic device, pacemakers or claustrophobia.
  • Patients with VP shunts
  • Patients with ventriculomegally due to brain SOLs.

Outcomes

Primary Outcomes

To calculate different cerebrospinal fluid flow parameters at different levels of flow quantification.

Time Frame: base line

measure Systolic stroke volume and Peak systolic velocity at different levels of flow quantification

Secondary Outcomes

  • To correlate these parameters to the normal values of age matched control group(baseline)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System Diseases
ISRCTN34007592Trinity Translational Medicine Institute12
Not yet recruiting
Not Applicable
Cerebrospinal Fluid and Psychiatric Disorders (CSFPsych)
NL-OMON47432niversitair Medisch Centrum Utrecht500
Active, not recruiting
Phase 1
An open-labelled study of the cerebrospinal fluid pharmacokinetics of intravenous Kineret® in patients with subarachnoid haemorrhage - IL-1RA in SAH PK STUDY 2This is a pharmacokinetic study in patients who have had a Subarachnoid Haemorrhage and who have had an external ventricular drain inserted for clinical management reasons, must usually for the treatment of hydrocephalus.MedDRA version: 9.1 Level: LLT Classification code 10042316 Term: Subarachnoid haemorrhageMedDRA version: 9.1 Level: LLT Classification code 10052947 Term: Ventricular drainageMedDRA version: 9.1 Level: LLT Classification code 10020508 Term: Hydrocephalus
EUCTR2007-002337-36-GBSalford Royal NHS Foundation Trust100
Terminated
Not Applicable
Cerebrospinal Fluid Collection and Repository StorageNervous System Diseases
NCT01862107National Institute of Neurological Disorders and Stroke (NINDS)51
Completed
Not Applicable
A study to examine cerebrospinal fluid transitivity and efficacy of afatinib in carcinomatous meningitis patients with non-small cell lung cancer patients harboring EGFR mutation.carcinomatous meningitis patients with NSCLC harboring EGFR mutation
JPRN-UMIN000014065Kinki-Chuo Chest Medical Center10